Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|May 8, 2013
Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblastsMarta Celegato, Cinzia Borghese, Naike Casagrande, et al.
International Journal of Molecular Sciences|August 27, 2021
Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor SpheroidsNaike Casagrande, Cinzia Borghese, Laura Gabbatore, et al.
Cancer Letters|April 8, 2014
The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphomaMarta Celegato, Cinzia Borghese, Kazuo Umezawa, et al.
International Journal of Molecular Sciences|April 3, 2021
In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and PaclitaxelNaike Casagrande, Cinzia Borghese, Francesco Agostini, et al.
Gynecologic Oncology|September 14, 2013
Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancerNaike Casagrande, Monica De Paoli, Marta Celegato, et al.
Journal of Medicinal Chemistry|October 24, 2022
Design, Synthesis, and Preclinical Activity in Ovarian Cancer Models of New Phosphanegold(I)-N-heterocyclic Carbene ComplexesAdam A A Sulaiman, Naike Casagrande, Cinzia Borghese, et al.
Journal of Cellular Biochemistry|November 30, 2012
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activityCinzia Borghese, Lara Cattaruzza, Eliana Pivetta, et al.
Future Medicinal Chemistry|August 28, 2014
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenograftsMarta Celegato, Dolores Fregona, Maurizio Mongiat, et al.
Oncotarget|May 7, 2017
Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cellsCinzia Borghese, Naike Casagrande, Eliana Pivetta, et al.
The Journal of Pathology|July 8, 2003
Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situGaetano Magro, Monica Schiappacassi, Daniela Perissinotto, et al.
Pageof 3